By Jocelyn Aspa
Trevena, AVEO, Aralez, Miragen and Curis top the NASDAQ biotech stock list.
The biotech sector has steadily enjoyed an increase this year, in part thanks to significant advancements and in spite of the uncertainty from the White House as the proposal of a new healthcare bill holds the grip of most life science markets.
MEI Pharma, AVEO Pharmaceuticals, Albireo Pharma, Athersys and CASI Pharmaceuticals top the list.
SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on Q BioMed Inc. (OTCQB:QBIO).
Q BioMed Inc. (OTCQB: QBIO) is a biomedical acceleration and development company focused on identifying, acquiring and licensing attractive biomedical assets from small
A recent report projected the medical device processing market value to reach $1.75 billion by 2020.
The biotechnology market has recently produced significant growth for all major life science indexes, thanks in part to oncology treatments.
AVEO, leads the list of last week’s life science gainers on the NASDAQ, followed by BioDelivery Sciences, Dynavax, Catalyst and Ekso Bionics.
The world’s pharmaceutical industry is dominated by the American and European markets. According to Forbes top companies of 2017, the 10 biggest drug companies are all located in these two regions.
Friday Night Inc, formerly QuikFlo Health Inc. (the “Company”) (CSE:TGIF) (FRANKFURT:1QF) announces that in conjunction with the closing of its previously announced acquisition of interests in two cannabis based businesses located in Las Vegas, Nevada, it has changed its name to Friday Night Inc. and consolidated its shares on a
BioSig Technologies (OTCQB:BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4+ billion electrophysiology (EP) marketplace, today announced that Ms. Natasha Russkina has joined the Company as Managing Director, Europe.
Natasha Russkina is founder and director of Augeous Consulting in Geneva, Switzerland,